RNF157 and myeloid sarcoma: Conversely, the RING E3 ligase RNF157 acts as a negative regulator of neuroinflammation, whose expression is downregulated in T cells from MS patients and negatively correlates with levels of the master Th17 transcription factor, RORγt [363, 364].